Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
AUTO-4(University College London) in Sarcoma: NCT07751380 Clinical Landscape Report 2026
11 September 2026
NCT07751380 clinical landscape for Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sacituzumab tirumotecan in Non-Muscle Invasive Bladder Urothelial Carcinoma: NCT07716917 Clinical Landscape Report 2026
11 September 2026
NCT07716917 clinical landscape for Non-Muscle Invasive Bladder Urothelial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Tezepelumab in Severe asthma: NCT07013123 Clinical Landscape Report 2026
11 September 2026
NCT07013123 clinical landscape for Severe asthma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HS-20118 in Plaque psoriasis: NCT07765628 Clinical Landscape Report 2026
11 September 2026
NCT07765628 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lenalidomide in Multiple Myeloma: NCT07764978 Clinical Landscape Report 2026
11 September 2026
NCT07764978 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma: NCT07806110 Clinical Landscape Report 2026
11 September 2026
NCT07806110 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Artenimol in Metabolic Dysfunction Associated Steatohepatitis: NCT07679542 Clinical Landscape Report 2026
11 September 2026
NCT07679542 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Trastuzumab in Ovarian Epithelial Carcinoma: NCT07779538 Clinical Landscape Report 2026
11 September 2026
NCT07779538 clinical landscape for Ovarian Epithelial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zipalertinib in Non-Small Cell Lung Cancer: NCT07802834 Clinical Landscape Report 2026
11 September 2026
NCT07802834 clinical landscape for Non-Small Cell Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SHR-2173 in Myasthenia Gravis: NCT07622342 Clinical Landscape Report 2026
11 September 2026
NCT07622342 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
UBT-251 in Sleep Apnea, Obstructive: NCT07806851 Clinical Landscape Report 2026
11 September 2026
NCT07806851 clinical landscape for Sleep Apnea, Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ipilimumab in Malignant Pleural Mesothelioma: NCT07532902 Clinical Landscape Report 2026
11 September 2026
NCT07532902 clinical landscape for Malignant Pleural Mesothelioma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.